• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Immunosuppressive therapy with cyclosporin A following penetrating keratoplasty].

作者信息

Gnad H D, Skorpik C, Radda T M, Paroussis P, Menapace R, Klemen U M

出版信息

Klin Monbl Augenheilkd. 1985 Nov;187(5):398-400. doi: 10.1055/s-2008-1054346.

DOI:10.1055/s-2008-1054346
PMID:3910946
Abstract

Report on 11 patients who underwent penetrating keratoplasty and were treated with Cyclosporin A for an average of 6 months because of excessive superficial and deep vascularization of the recipient cornea. In none of the patients was a permanent Cyclosporin A-induced side-effect observed. After an average follow-up period of 11 months 9 grafts remained completely clear; however, an allograft-reaction occurred in 2 cases in spite of the immunosuppressive therapy.

摘要

相似文献

1
[Immunosuppressive therapy with cyclosporin A following penetrating keratoplasty].
Klin Monbl Augenheilkd. 1985 Nov;187(5):398-400. doi: 10.1055/s-2008-1054346.
2
[Preventive systemic cyclosporin A in risk keratoplasty].[预防性全身应用环孢素A在高危角膜移植术中的应用]
Klin Monbl Augenheilkd. 1990 Dec;197(6):466-9. doi: 10.1055/s-2008-1046313.
3
[Immunosuppression with cyclosporin A in high-risk keratoplasties].[高危角膜移植中环孢素A的免疫抑制作用]
Klin Monbl Augenheilkd. 1985 Nov;187(5):394-7. doi: 10.1055/s-2008-1054345.
4
[Systemic cyclosporin A therapy in high risk keratoplasty].[全身应用环孢素A治疗高危角膜移植术]
Fortschr Ophthalmol. 1989;86(6):574-80.
5
[Keratoplasty in private practice].[私人执业中的角膜移植术]
Klin Monbl Augenheilkd. 1990 May;196(5):304-6. doi: 10.1055/s-2008-1046177.
6
Predicted long-term outcome of corneal transplantation.角膜移植的预测长期结果。
Ophthalmology. 2009 Dec;116(12):2354-60. doi: 10.1016/j.ophtha.2009.05.009. Epub 2009 Oct 7.
7
Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection.
Jpn J Ophthalmol. 1989;33(2):212-20.
8
[Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].[207例患者的前瞻性“埃尔朗根非高危穿透性角膜移植术研究”中期结果]
Klin Monbl Augenheilkd. 2000 Sep;217(3):163-70. doi: 10.1055/s-2000-10340.
9
[Possibilities of immunosuppressive therapy in reconstructive keratoplasty (experience gained in the use of cyclosporin)].[重建角膜移植术中免疫抑制治疗的可能性(使用环孢素的经验)]
Vestn Oftalmol. 2002 Jul-Aug;118(4):16-8.
10
Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.角膜移植排斥反应的危险因素:一项前瞻性正常风险角膜移植研究的中期结果
Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):580-4. doi: 10.1007/s00417-002-0496-5. Epub 2002 Jun 21.

引用本文的文献

1
Systemic ciclosporin A in high-risk keratoplasties.全身应用环孢素A在高危角膜移植术中的应用
Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234 Suppl 1:S115-21. doi: 10.1007/BF02343059.